Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2025

Workshop in collaboration with ESMO YOC: Evaluation of phase I data at the end of the study for next planning of drug development

How do we pick a recommended dose: Safe may be, but optimised?

Date

05 Mar 2025

Session

Workshop in collaboration with ESMO YOC: Evaluation of phase I data at the end of the study for next planning of drug development

Topics

Clinical Research;  Statistics

Tumour Site

Presenters

Elena Garralda

Authors

E. Garralda

Author affiliations

  • Early Drug Development Dept., Vall d'Hebron University Hospital, 8035 - Barcelona/ES

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Session: Workshop in collaboration with ESMO YOC: Evaluation of phase I data at the end of the study for next planning of drug development

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.